Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)

PURPOSE: Cariprazine is a potent dopamine D(3)-preferring D(3)/D(2) receptor partial agonist in development for the treatment of schizophrenia, bipolar mania, and depression. Pharmacokinetics of cariprazine and the two clinically relevant metabolites (desmethyl- and didesmethyl-cariprazine) was eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Tadakatsu, Kubota, Tomoko, Iwakaji, Atsushi, Imada, Masayoshi, Kapás, Margit, Morio, Yasunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716719/
https://www.ncbi.nlm.nih.gov/pubmed/26834462
http://dx.doi.org/10.2147/DDDT.S95100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716719/
https://www.ncbi.nlm.nih.gov/pubmed/26834462
http://dx.doi.org/10.2147/DDDT.S95100

Ejemplares similares